Skip to content
PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗?(Chinese-language podcast) episode artwork

EPISODE · Apr 24, 2026 · 12 MIN

PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗?(Chinese-language podcast)

from Citeline Podcasts · host Norstella

本期《中国生物技术播客》聚焦康方生物的依沃西单抗将如何改写历史,以及在PD-(L)1/VEGF双抗之间是否即将发生国内头对头三期临床试验。 Could PD-(L)1/VEGF Agents Face Off First In China Phase III Trials?

Episode metadata supplied by the publisher feed · Published Apr 24, 2026

Embed this episode

Ready to play

PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗?(Chinese-language podcast)

0:00 12:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 12 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on April 24, 2026.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!